Fulgent Genetics (FLGT) Change in Receivables (2015 - 2026)

Fulgent Genetics has reported Change in Receivables for 12 years, with the latest figure at -$729000.0 in Q2 2026.

• Quarterly Change in Receivables fell 108.83% year-over-year to -$729000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$6.7 million (down 124.16% YoY) and the FY2025 annual result came in at $23.3 million, up 42.62% from the prior year.
• Change in Receivables climbed to -$729000.0 in Q2 2026 per FLGT's latest filing, from -$16.4 million in the prior quarter.
• Over five years, Change in Receivables peaked at $32.9 million in Q1 2022 and troughed at -$44.4 million in Q4 2022.
• A 5-year average of -$2.7 million and a median of $428000.0 in 2024 frame the typical range for Change in Receivables.
• The sharpest annual moves came in 2025 and 2026: Change in Receivables jumped 404.85% in 2025, then slumped 463.2% in 2026.
• Over 5 years, Change in Receivables stood at -$44.4 million in 2022, then soared by 111.72% to $5.2 million in 2023, then surged by 155.86% to $13.3 million in 2024, then rose by 15.4% to $15.4 million in 2025, then plunged by 104.74% to -$729000.0 in 2026.
• According to Business Quant data, Change in Receivables over the past three periods registered -$729000.0, -$16.4 million, and $15.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.